Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PRKCA | P17252 | 1/20 | 0.44 |
| ▸ | DGKA | P23743 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.33 |
| ▸ | ADRB1 | P08588 | 3/20 | 0.33 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.33 |
| ▸ | AR | P10275 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14727838 | 0.85 | PRKCA (0.60) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL11231395 | 0.82 | KDM4E (0.43) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL13217413 | 0.82 | KDM4E (0.43) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL27051353 | 0.82 | LMNA (0.43) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL11306638 | 0.82 | KDM4E (0.43) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL14700446 | 0.82 | KDM4E (0.43) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL14563307 | 0.82 | KDM4E (0.43) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL26548897 | 0.81 | KDM4E (0.40) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL6056807 | 0.80 | KDM4E (0.42) | LMNAKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL116867 | 0.80 | LMNA (0.46) | LMNAKDM4EDUSP3MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230332008-A1 | PHENOL COMPOUND, CONDUCTIVE PASTE COMPOSITION, METHOD FOR PRODUCING CONDUCTIVE PASTE COMPOSITION, CONDUCTIVE WIRE, AND METHOD FOR PRODUCING CONDUCTIVE WIRE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-10-19 | — | — | US | disclosed |
| US-20220157484-A1 | POLYURETHANE, POLYURETHANE PRODUCTION METHOD, CONDUCTIVE PASTE COMPOSITION, CONDUCTIVE WIRE, AND METHOD FOR PRODUCING CONDUCTIVE WIRE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2022-05-19 | — | — | US | disclosed |
| CN-101248055-B | Process for producing glycidyl 2-hydroxyisobutyrate and composition containing the product | MITSUBISHI GAS CHEMICAL CO | 2012-01-25 | — | — | CN | disclosed |
| CN-101248055-A | Process for producing glycidyl 2-hydroxyisobutyrate and composition containing the product | MITSUBISHI GAS CHEMICAL CO (JP) | 2008-08-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230332008-A1 | PHENOL COMPOUND, CONDUCTIVE PASTE COMPOSITION, METHOD FOR PRODUCING CONDUCTIVE PASTE COMPOSITION, CONDUCTIVE WIRE, AND METHOD FOR PRODUCING CONDUCTIVE WIRE | COL1A1, MYB, HES1 | LMNA 882/4885KDM4E 417/4885DUSP3 4465/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.